Skip to content
Home/Companies/Pharma/Scantox

Scantox

Pharma·Denmark·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Scantox?

Scantox is currently owned by Impilo through Impilo Investment Pool 2 (2021 vintage), since 2021.

Hand-verified · updated 2026-08-17

Impilo
Investor
Impilo
Impilo Investment Pool 2 · 2021 · Buyout

Key facts

HQDenmark
SectorPharma
StatusActive

More from Impilo Investment Pool 2

Other portfolio companies in the same fund.

Avia Pharma
Active
PharmaSweden· 2024
Qufora
Active
MedTechDenmark· 2024
Tandlaegen.dk
Active
HealthcareDenmark· 2024
Decon
Active
MedTechSweden· 2023
Pelago Bioscience
Active
PharmaSweden· 2023
Stille
Active
MedTechSweden· 2023

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Scantox

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Scantox?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Scantox.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue